IsoRay Inc Performance

ISRDelisted Stock  USD 0.38  0.01  2.70%   
The company retains a Market Volatility (i.e., Beta) of 0.0349, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IsoRay's returns are expected to increase less than the market. However, during the bear market, the loss of holding IsoRay is expected to be smaller as well. IsoRay Inc right now retains a risk of 0.0%. Please check out IsoRay value at risk, as well as the relationship between the kurtosis and market facilitation index , to decide if IsoRay will be following its current trending patterns.

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days IsoRay Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, IsoRay is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
Begin Period Cash Flow64 M
Total Cashflows From Investing Activities-284 K
  

IsoRay Relative Risk vs. Return Landscape

If you would invest  38.00  in IsoRay Inc on December 29, 2023 and sell it today you would earn a total of  0.00  from holding IsoRay Inc or generate 0.0% return on investment over 90 days. IsoRay Inc is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than IsoRay, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  

IsoRay Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for IsoRay's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IsoRay Inc, and traders can use it to determine the average amount a IsoRay's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ISR
Based on monthly moving average IsoRay is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IsoRay by adding IsoRay to a well-diversified portfolio.

IsoRay Fundamentals Growth

IsoRay Stock prices reflect investors' perceptions of the future prospects and financial health of IsoRay, and IsoRay fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IsoRay Stock performance.

About IsoRay Performance

To evaluate IsoRay Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when IsoRay generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare IsoRay Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand IsoRay Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents IsoRay's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people.

Things to note about IsoRay Inc performance evaluation

Checking the ongoing alerts about IsoRay for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IsoRay Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
IsoRay Inc is not yet fully synchronised with the market data
IsoRay Inc has some characteristics of a very speculative penny stock
IsoRay Inc has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 10.79 M. Reported Net Loss for the year was (7.27 M) with profit before taxes, overhead, and interest of 4.62 M.
IsoRay Inc has about 55.89 M in cash with (7.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating IsoRay's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate IsoRay's stock performance include:
  • Analyzing IsoRay's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IsoRay's stock is overvalued or undervalued compared to its peers.
  • Examining IsoRay's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating IsoRay's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IsoRay's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of IsoRay's stock. These opinions can provide insight into IsoRay's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating IsoRay's stock performance is not an exact science, and many factors can impact IsoRay's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in IsoRay Stock

If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing